Neuroendocrine control of natural killer cell function through the checkpoint molecule PD-1

被引：0
|
作者：
Justine Devulder
Anne Tsicopoulos
Catherine Duez
机构：
[1] Institut National de la Santé Et de la Recherche Médicale,Pulmonary Immunity
[2] U1019,Institut Pasteur de Lille
[3] Center for Infection and Immunity of Lille,undefined
[4] CNRS UMR 8204,undefined
[5] Univ Lille Nord de France,undefined
[6] Clinique des Maladies Respiratoires et Centre Hospitalier Régional et Universitaire de Lille,undefined
来源：
Cellular & Molecular Immunology | 2019年 / 16卷
关键词：
Neuroendocrine Control; MCMV Infection; Quatrini; Murine Cytomegalovirus; Reduce Pathogen Burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 111
页数：2
相关论文
共 50 条
  • [31] T-cell Characteristics of Patients with malignant Melanoma as a Function of Therapy with PD-1 Immune Checkpoint Inhibitors
    Werner, M.
    Pfoehler, C.
    Sester, M.
    Schmidt, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 28 - 28
  • [32] Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint
    Konieczny, Magdalena
    Musielak, Bogdan
    Kocik, Justyna
    Skalniak, Lukasz
    Sala, Dominik
    Czub, Miroslawa
    Magiera-Mularz, Katarzyna
    Rodriguez, Ismael
    Myrcha, Maja
    Stec, Malgorzata
    Siedlar, Maciej
    Holak, Tad A.
    Plewka, Jacek
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11271 - 11285
  • [33] Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
    Sampedro-Nunez, Miguel
    Serrano-Somavilla, Ana
    Adrados, Magdalena
    Cameselle-Teijeiro, Jose M.
    Blanco-Carrera, Concepcion
    Manuel Cabezas-Agricola, Jose
    Martinez-Hernandez, Rebeca
    Martin-Perez, Elena
    Munoz de Nova, Jose Luis
    Angel Diaz, Jose
    Garcia-Centeno, Rogelio
    Caneiro-Gomez, Javier
    Abdulkader, Ihab
    Gonzalez-Amaro, Roberto
    Marazuela, Monica
    SCIENTIFIC REPORTS, 2018, 8
  • [34] PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
    Trefny, Marcel P.
    Kaiser, Monika
    Stanczak, Michal A.
    Herzig, Petra
    Savic, Spasenija
    Wiese, Mark
    Lardinois, Didier
    Laeubli, Heinz
    Uhlenbrock, Franziska
    Zippelius, Alfred
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (08) : 1505 - 1517
  • [35] PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
    Marcel P. Trefny
    Monika Kaiser
    Michal A. Stanczak
    Petra Herzig
    Spasenija Savic
    Mark Wiese
    Didier Lardinois
    Heinz Läubli
    Franziska Uhlenbrock
    Alfred Zippelius
    Cancer Immunology, Immunotherapy, 2020, 69 : 1505 - 1517
  • [36] Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
    Miguel Sampedro-Núñez
    Ana Serrano-Somavilla
    Magdalena Adrados
    José M. Cameselle-Teijeiro
    Concepción Blanco-Carrera
    José Manuel Cabezas-Agricola
    Rebeca Martínez-Hernández
    Elena Martín-Pérez
    José Luis Muñoz de Nova
    José Ángel Díaz
    Rogelio García-Centeno
    Javier Caneiro-Gómez
    Ihab Abdulkader
    Roberto González-Amaro
    Mónica Marazuela
    Scientific Reports, 8
  • [37] T-Cell Intrinsic Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Krogsgaard, Michelle
    Moogk, Duane
    Wang, Lin
    Li, Kaito
    Yuan, Zhou
    Weber, Jeffrey
    Osman, Iman
    Zhu, Cheng
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [38] T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade
    Moogk, Duane
    Wang, Lin
    Li, Kaitao
    Yuan, Zhou
    Weber, Jeffrey
    Osman, Iman
    Zhu, Cheng
    Krogsgaard, Michelle
    CANCER RESEARCH, 2019, 79 (13)
  • [39] PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
    Aaron Goodman
    Sandip P. Patel
    Razelle Kurzrock
    Nature Reviews Clinical Oncology, 2017, 14 : 203 - 220
  • [40] Analysis of mTOR CXCR4 and PD-1 checkpoint pathways in Merkel cell neuroendocrine carcinomas: correlations with prognosis and viral status
    Deschamps, L.
    Benhamou, J.
    Sugier, P. E.
    Vergier, B.
    Pham-Ledard, A.
    Carlotti, A.
    Avril, M.
    Ortonne, N.
    Zehour, O.
    Durlach, A.
    Grange, F.
    Balme, B.
    Dalle, S.
    Zimmermann, U.
    Blom, A.
    Lorton, M. H.
    Dalac, S.
    Couvelard, A.
    Maubec, E.
    VIRCHOWS ARCHIV, 2019, 475 : S108 - S108
12345